Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (491-500 of 548) with videos related to

Pageof 55
Sort By:
Genome Biology|April 6, 2023
Flexible and efficient handling of nanopore sequencing signal data with slow5toolsHiruna Samarakoon, James M Ferguson, Sasha P Jenner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Administration of MPTP to the common marmoset does not alter cortical cholinergic functionJ Garvey, M Petersen, C M Waters, et al.
Biochemical Pharmacology|October 17, 1998
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's diseaseK S McNaught, P A Carrupt, C Altomare, et al.
Experimental Neurology|March 31, 2000
Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeysT Kanda, M J Jackson, L A Smith, et al.
Synapse (New York, N.Y.)|October 25, 2000
Expression and distribution of CYP2C enzymes in rat basal gangliaA G Riedl, P M Watts, D C Douek, et al.
Annals of Neurology|December 1, 1994
Complex I, iron, and ferritin in Parkinson's disease substantia nigraV M Mann, J M Cooper, S E Daniel, et al.
European Journal of Pharmacology|August 3, 1989
Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437P A Löschmann, P N Chong, M Nomoto, et al.
Nature|January 2, 1986
1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathwayA J Bradbury, B Costall, A M Domeney, et al.
Biochemical Pharmacology|January 31, 1995
Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugsI Jeding, P J Evans, D Akanmu, et al.
Annals of Neurology|April 18, 1998
Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeysT Kanda, M J Jackson, L A Smith, et al.
Pageof 55

Showing results (491-500 of 548) with videos related to

Sort By:
Pageof 55
Genome Biology|April 6, 2023
Flexible and efficient handling of nanopore sequencing signal data with slow5toolsHiruna Samarakoon, James M Ferguson, Sasha P Jenner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Administration of MPTP to the common marmoset does not alter cortical cholinergic functionJ Garvey, M Petersen, C M Waters, et al.
Biochemical Pharmacology|October 17, 1998
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's diseaseK S McNaught, P A Carrupt, C Altomare, et al.
Experimental Neurology|March 31, 2000
Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeysT Kanda, M J Jackson, L A Smith, et al.
Synapse (New York, N.Y.)|October 25, 2000
Expression and distribution of CYP2C enzymes in rat basal gangliaA G Riedl, P M Watts, D C Douek, et al.
Annals of Neurology|December 1, 1994
Complex I, iron, and ferritin in Parkinson's disease substantia nigraV M Mann, J M Cooper, S E Daniel, et al.
European Journal of Pharmacology|August 3, 1989
Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437P A Löschmann, P N Chong, M Nomoto, et al.
Nature|January 2, 1986
1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathwayA J Bradbury, B Costall, A M Domeney, et al.
Biochemical Pharmacology|January 31, 1995
Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugsI Jeding, P J Evans, D Akanmu, et al.
Annals of Neurology|April 18, 1998
Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeysT Kanda, M J Jackson, L A Smith, et al.
Pageof 55